Q32 Bio Inc. — Director's Dealing 2021

Feb 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Homology Medicines, Inc. (FIXX)
CIK: 0001661998
Period of Report: 2021-02-05

Reporting Person: Seymour Albert (Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-05	Employee Stock Option (Right to Buy)	$13.78	A	78000	Acquired	2031-02-05	Common Stock (78000)	Direct
2021-02-05	Restricted Stock Units	$	A	13000	Acquired		Common Stock (13000)	Direct

Footnotes

F1: The option vests in 48 equal monthly installments on the first day of each calendar month following January 1, 2021.

F2: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F3: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024.